Literature DB >> 1336073

Abnormal lipid and lipoprotein patterns in liver cirrhosis with and without hepatocellular carcinoma.

J E Ahaneku1, G O Taylor, I O Olubuyide, E O Agbedana.   

Abstract

Plasma lipid and lipoprotein profile was determined in 12 cirrhotics, 15 patients with cirrhosis and hepatocellular carcinoma (HCC) and 20 healthy volunteers. When compared with controls plasma total cholesterol (TC), high density lipoprotein cholesterol (HDLC), high density lipoprotein phospholipids (HDLPL), HDLPL/PL levels were low, phospholipid (PL) was normal and HDLC/TC and PL/TC were high in cirrhosis. In cirrhotics with HCC, TC, PL, PL/TC levels were elevated while HDLC, HDPL, HDLC/TC and HDLPL/PL were normal. A comparison within the patient groups showed that in cirrhosis alone, the levels of TC, HDLC, PL, HDLPL and HDLPL/PL were lower and PL/TC level was higher than in cirrhotics with HCC. Plasma albumin levels showed a negative correlation with PL/TC and a positive correlation with HDL-cholesterol in cirrhosis. In cirrhosis with HCC plasma, phospholipid levels showed a significant negative correlation with total bilirubin and alanine aminotransferase. The variations in the level of plasma lipids and lipoproteins may assist in describing the nature of these two forms of liver disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336073

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  13 in total

1.  Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.

Authors:  Ramesh Chandra Halder; Cynthia Tran; Priti Prasad; Jing Wang; Dhiraj Nallapothula; Tatsuya Ishikawa; Meiying Wang; Dirk M Zajonc; Ram Raj Singh
Journal:  Eur J Immunol       Date:  2018-12-18       Impact factor: 5.532

2.  Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.

Authors:  Jian-Min Wu; Nicholas J Skill; Mary A Maluccio
Journal:  HPB (Oxford)       Date:  2010-11       Impact factor: 3.647

3.  B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer.

Authors:  Chun-che Lin; Mei-chin Yin
Journal:  Eur J Nutr       Date:  2007-06-14       Impact factor: 5.614

4.  The relationship between lipid profile and severity of liver damage in cirrhotic patients.

Authors:  Mohammad Reza Ghadir; Ali Akbar Riahin; Abbas Havaspour; Mehrdad Nooranipour; Abbas Ali Habibinejad
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

5.  Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma.

Authors:  Mario Uccello; Giulia Malaguarnera; Elisa M Pelligra; Antonio Biondi; Francesco Basile; Massimo Motta
Journal:  Indian J Med Paediatr Oncol       Date:  2011-04

6.  Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection.

Authors:  Xiao-Chun Ni; Yong Yi; Yi-Peng Fu; Xiao-Yan Cai; Gao Liu; Jin-Long Huang; Wei Gan; Jie Xu; Shuang-Jian Qiu
Journal:  Onco Targets Ther       Date:  2020-12-16       Impact factor: 4.147

7.  Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases.

Authors:  Jingting Jiang; Xiaoying Zhang; Changping Wu; Xihu Qin; Guanghua Luo; Haifeng Deng; Minyang Lu; Bin Xu; Min Li; Mei Ji; Ning Xu
Journal:  Lipids Health Dis       Date:  2008-07-24       Impact factor: 3.876

Review 8.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

9.  The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma.

Authors:  Shan-Shan Jiang; De-Sheng Weng; Long Jiang; Yao-Jun Zhang; Ke Pan; Qiu-Zhong Pan; Chang-Long Chen; Jing-Jing Zhao; Xiao-Fei Zhang; Hong-Xia Zhang; Yan Tang; Zi-Qi Zhou; Min-Shan Chen; Jian-Chuan Xia
Journal:  J Cancer       Date:  2016-03-20       Impact factor: 4.207

10.  A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.

Authors:  Minjie Mao; Xueping Wang; Hui Sheng; Yijun Liu; Lin Zhang; Shuqin Dai; Pei-Dong Chi
Journal:  BMC Cancer       Date:  2018-11-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.